New management in the Animal Nutrition division at Alzchem
Starting May 1, 2022, Andreas Oebbeke has taken over as head of the Animal Nutrition division at Alzchem Group AG in Trostberg.
"We are pleased to welcome Andreas Oebbeke, a renowned and experienced expert, to lead our Animal Nutrition business," said Alzchem Management Board member Dr. Georg Weichselbaumer. "He will take our Creamino® business to the next level and now drive our global growth strategy after the first already very successful years of building it up."
Andreas Oebbeke has known the industry for decades: After training as a farmer, he successfully completed a degree in agricultural science with a focus on animal production and animal nutrition at the University of Bonn. In the following 30 years he held leading positions at major companies in the German and international feed/feed additives industry, most recently as Sales Director at a global leader in animal nutrition. This exceptional combination of scientific expertise, practical know-how and a direct, hands-on manner will now benefit Alzchem's customers: "We want to create added value for the customer, that is our top priority," emphasizes Oebbeke. "Increasing efficiency in animal production will play an important role in global food security. And with Creamino®, we have an innovative and thereby already proven technology that makes this possible to a significant extent: we help feeding the world - that's our mission."
About Creamino®
Creamino® is a patented feed additive with the main active ingredient guanidinoacetic acid (GAA) and thus represents the direct, endogenous precursor of creatine in the organism of all vertebrates. The body produces GAA from the amino acids glycine and arginine and then converts GAA to creatine with the help of methionine; however, this endogenous production is not sufficient to meet the daily requirement. Creatine is not present in conventional commercial feeds. As an essential biomolecule, creatine is responsible for the proper function of energy transfer and supply, supporting healthy growth, strengthening the immune system, and increasing reproductive success. Unlike other nutrients, creatine directly recharges ATP for energy supply and ensures that sufficient energy is available in the body at all times and in all places.
With Creamino® we supply a unique creatine source from German production, which is converted to creatine in the animal and supports many important body functions - Energy for healthy growth.
Contact
Sabine Sieber
Head of Corporate Communications & Investor Relations
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2021, Alzchem generated consolidated sales of around EUR 422.3 million and EBITDA of around EUR 62.0 million.